Overview

A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The value of banding ligation plus beta blocker in the prophylaxis of first episodes of variceal bleeding has not yet been evaluated. This study was conducted to compare the efficacy and safety of banding ligation plus nadolol versus nadolol in the prophylaxis of first bleeding in cirrhotic patients with high-risk esophageal varices.
Phase:
Phase 4
Details
Lead Sponsor:
National Science Council, Taiwan
Treatments:
Adrenergic beta-Antagonists
Nadolol